|
|
Volumn 346, Issue 9, 2002, Pages 712-713
|
|
Adverse events after imatinib mesylate therapy [8] (multiple letters)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
HYDROXYUREA;
IMATINIB;
PLATELET DERIVED GROWTH FACTOR RECEPTOR;
ANTINEOPLASTIC AGENT;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
ADULT;
AGED;
BONE MARROW NECROSIS;
BONE NECROSIS;
CASE REPORT;
CHRONIC MYELOMONOCYTIC LEUKEMIA;
CLINICAL FEATURE;
CYTOGENETICS;
DISEASE COURSE;
DRUG STABILITY;
DRUG WITHDRAWAL;
EDEMA;
FEMALE;
FEVER;
GASTROINTESTINAL SYMPTOM;
HEMATOPOIESIS;
HUMAN;
HUMAN TISSUE;
LETTER;
LIVER FUNCTION TEST;
MALE;
MYELOFIBROSIS;
PAIN ASSESSMENT;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
RIGOR;
SIGNAL TRANSDUCTION;
SPLEEN RUPTURE;
SPLENECTOMY;
SPLENOMEGALY;
STEM CELL TRANSPLANTATION;
THROMBOCYTOSIS;
TREATMENT OUTCOME;
CHEMICALLY INDUCED DISORDER;
MIDDLE AGED;
RADIOGRAPHY;
BONE MARROW;
CHRONIC MYELOID LEUKEMIA;
NECROSIS;
PATHOLOGY;
AGED;
ANTINEOPLASTIC AGENTS;
FEMALE;
HUMANS;
LEUKEMIA, MYELOMONOCYTIC, CHRONIC;
MIDDLE AGED;
MYELOFIBROSIS;
PIPERAZINES;
PYRIMIDINES;
SPLENIC RUPTURE;
SPLENOMEGALY;
BONE MARROW;
LEUKEMIA, MYELOID, CHRONIC;
MALE;
NECROSIS;
|
|
EID: 0037187072
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200202283460919 Document Type: Letter |
|
Times cited : (46)
|
|
References (0)
|
